Vaporox Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.5M
- Investors
-
9
Vaporox General Information
Description
Developer of a hyperoxia therapy technology designed to treat diabetic foot ulcers. The company's technology provides low-frequency, non-contact, and non-thermal ultrasound that atomizes a liquid with optional antimicrobials to deliver it continuously to the wound bed, enabling patients to get access to a comfortable treatment option that prevents amputations at a low cost.
Contact Information
Website
vaporox.comCorporate Office
- 8375 South Willow Street
- Suite 500
- Lone Tree, CO 80124
- United States
Corporate Office
- 8375 South Willow Street
- Suite 500
- Lone Tree, CO 80124
- United States
Vaporox Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 05-Sep-2023 | $2.5M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series A) | 13-Sep-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 16-Aug-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 08-Mar-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 15-Jan-2020 | $1.53M | $2M | Completed | Clinical Trials - General | |
| 1. Seed Round | 25-Mar-2019 | $470K | $470K | Completed | Pre-Clinical Trials |
Vaporox Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed Series 3 | ||||||||
| Seed Series 2 | 1,025,000 | $0.000100 | 5% | $1.5 | $1.5 | 1x | $1.5 | 12.05% |
| Seed Series 1 | 1,095,000 | $0.000100 | 5% | $0.43 | $0.43 | 1x | $0.43 | 12.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vaporox Comparisons
Industry
Financing
Details
Vaporox Competitors (4)
One of Vaporox’s 4 competitors is EO2 Concepts, a Venture Capital-Backed company based in San Antonio, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| EO2 Concepts | Venture Capital-Backed | San Antonio, TX | ||||
| Natrox | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Advanced Oxygen Therapy | Formerly Private Debt Financed | Oceanside, CA | ||||
| Sanuwave Health | Formerly PE-Backed | Eden Prairie, MN |
Vaporox Patents
Vaporox Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021378393-A1 | Multistage vaporizer for medical treatment system | Pending | 16-Nov-2020 | ||
| AU-2021378393-A9 | Multistage vaporizer for medical treatment system | Pending | 16-Nov-2020 | ||
| CA-3201492-A1 | Multistage vaporizer for medical treatment system | Pending | 16-Nov-2020 | ||
| EP-4243902-A1 | Multistage vaporizer for medical treatment system | Pending | 16-Nov-2020 | ||
| EP-4243902-A4 | Multistage vaporizer for medical treatment system | Pending | 16-Nov-2020 | A61M11/005 |
Vaporox Signals
Vaporox Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Card Sound Partners | PE/Buyout | Minority | ||
| Rockies Seed Fund | Venture Capital | Minority | ||
| Bioventus | Corporation | Minority | ||
| Innosphere Ventures | Accelerator/Incubator | Minority | ||
| Lateral Capital Management | Venture Capital | Minority |
Vaporox FAQs
-
When was Vaporox founded?
Vaporox was founded in 2016.
-
Where is Vaporox headquartered?
Vaporox is headquartered in Lone Tree, CO.
-
What is the size of Vaporox?
Vaporox has 12 total employees.
-
What industry is Vaporox in?
Vaporox’s primary industry is Therapeutic Devices.
-
Is Vaporox a private or public company?
Vaporox is a Private company.
-
What is Vaporox’s current revenue?
The current revenue for Vaporox is .
-
How much funding has Vaporox raised over time?
Vaporox has raised $12.2M.
-
Who are Vaporox’s investors?
Card Sound Partners, Rockies Seed Fund, Bioventus, Innosphere Ventures, and Lateral Capital Management are 5 of 9 investors who have invested in Vaporox.
-
Who are Vaporox’s competitors?
EO2 Concepts, Natrox, Advanced Oxygen Therapy, and Sanuwave Health are competitors of Vaporox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process